Our Chief Scientific Officer, Dr David Reynolds looks back at key milestones in dementia research in 2018. The past 12 months have seen many important developments across the dementia research landscape– a field that unites governments and industry with health services and research institutes in urgent action to tackle diseases that affect more than 50 […]
There are certain moments in life that, when looking back, stand out above the rest. It’s no different in scientific discovery – a journey of exploration, where important discoveries pave the way for the breakthroughs that change lives. Here are some of the most influential advances in dementia research over the last century – thank […]
Last year we brought you Santa Forgot, a thought-provoking story imagining a world where Father Christmas is living with dementia. In the time since we launched the campaign, this powerful message will have become a stark reality for families all over the country. Around 200,000 people in the UK will have developed dementia in […]
It’s been a long and agonising wait for clinical trial results to show whether a treatment called solanezumab could be the first new drug licenced for Alzheimer’s in over a decade. But today, hopes seem to have faded for the drug after it failed to meet its primary endpoint in another phase III clinical trial. […]
